Literature DB >> 2241284

Mast cells in the labial salivary glands of patients with Sjögren's syndrome: a histochemical, immunohistochemical, and electron microscopical study.

Y T Konttinen1, S Tuominen, M Segerberg-Konttinen, P Jungell, M J Malmström, M Grönblad, O Guven, S Santavirta, P Panula.   

Abstract

Mast cells in labial salivary glands obtained from patients with xerostomia with or without focal sialadenitis/Sjögren's syndrome were studied. There was no significant correlation between the intensity of local lymphocyte infiltration and the morphometrically analysed number of mast cells staining positive with toluidine blue. Histamine staining with heterologous 11C antiserum showed significantly fewer positive cells than staining with toluidine blue (mean (SD) 62 (10) v 138 (30)). This suggests heterogeneity of the mast cell population. Furthermore, there was a correlation between the focus score and the number of mast cells containing histamine. This suggests that the proliferation of mast cells containing histamine may be locally regulated by the immune inflammation, possibly through mediators from macrophages and fibroblasts. In contrast, the number of mast cells staining positive with toluidine blue could not be used as a marker of the degree of local inflammation. Although transmission electron microscopic analysis did not disclose signs of 'en masse' mast cell degranulation, mast cells may have a role in the local disease process.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2241284      PMCID: PMC1004204          DOI: 10.1136/ard.49.9.685

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  18 in total

Review 1.  Mast cells, mediators and asthma.

Authors:  S T Holgate; A B Kay
Journal:  Clin Allergy       Date:  1985-05

2.  Characterization and functional studies of rheumatoid synovial mast cells. Activation by secretagogues, anti-IgE, and a histamine-releasing lymphokine.

Authors:  B Gruber; M Poznansky; E Boss; J Partin; P Gorevic; A P Kaplan
Journal:  Arthritis Rheum       Date:  1986-08

Review 3.  The histopathology of Sjögren's syndrome in labial salivary gland biopsies.

Authors:  J S Greenspan; T E Daniels; N Talal; R A Sylvester
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1974-02

4.  The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.

Authors:  L A Sternberger; P H Hardy; J J Cuculis; H G Meyer
Journal:  J Histochem Cytochem       Date:  1970-05       Impact factor: 2.479

Review 5.  Basophils and mast cells: morphologic insights into their biology, secretory patterns, and function.

Authors:  S J Galli; A M Dvorak; H F Dvorak
Journal:  Prog Allergy       Date:  1984

6.  The mast cell and synovial inflammation. Or, what's a nice cell like you doing in a joint like this?

Authors:  S I Wasserman
Journal:  Arthritis Rheum       Date:  1984-08

Review 7.  Mediators of human mast cells and human mast cell subsets.

Authors:  L B Schwartz
Journal:  Ann Allergy       Date:  1987-04

8.  Histamine-containing neurons in the rat hypothalamus.

Authors:  P Panula; H Y Yang; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

Review 9.  The mast cell.

Authors:  D D Metcalfe; M Kaliner; M A Donlon
Journal:  Crit Rev Immunol       Date:  1981-09       Impact factor: 2.214

Review 10.  Effector cell heterogeneity in immediate hypersensitivity reactions.

Authors:  D D Metcalfe
Journal:  Clin Rev Allergy       Date:  1983-09
View more
  2 in total

1.  Inflammation of the subacromial bursa in chronic shoulder pain.

Authors:  S Santavirta; Y T Konttinen; I Antti-Poika; D Nordström
Journal:  Arch Orthop Trauma Surg       Date:  1992       Impact factor: 3.067

2.  Mast cells as a target in the treatment of rheumatoid arthritis.

Authors:  O Bakharevski; P F Ryan
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.